Immunic

formerly Immunic TherapeuticsIPO

Immunic is a biotech company in New York, United States, founded in 2016. It has raised $694.9M across 4 rounds, most recently a $400.0M Private Equity in February 2026.

Home - Immunic Therapeutics

Headquarters
New York, New York
Employees
51–200
Founded
2016
Business Model
B2B
Website
imux.com
Total Funding
$694.9M
Last Round
$400.0M Private EquityFeb 2026
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Immunic, Inc. (Nasdaq: IMUX) is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and autoimmune diseases. Its lead program, vidofludimus calcium (IMU-838), is in Phase 3 trials for relapsing multiple sclerosis. Founded in 2016 as Immunic AG in Germany, the company redomiciled to the United States in 2019 and is headquartered in New York City.

Summary

It lists 51–200 employees. It has raised $694.9M in total across 4 rounds, most recently a $400.0M Private Equity round in Feb 2026. Investors include High-Tech Grunderfonds, Boehringer Ingelheim Venture Fund and Omega Funds.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Private EquityPrivate EquityFeb 2026
$400.0M

Sign up to see all 4 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Immunic on Indexed.vc
<a href="https://indexed.vc/companies/immunic"><img src="https://indexed.vc/api/badge/company/immunic" alt="Immunic on Indexed.vc" width="260" height="76" /></a>